Pharmacokinetics of carbon nanoparticle-paclitaxel suspension for use in intraperitoneal chemotherapy.
To study the pharmacokinetics of carbon nanoparticle-paclitaxel suspension (CNPS) in intraperitoneal chemotherapy. Thirty-three Wistar rats were randomly assigned to an experimental group (A) and a control group (B), to which intraperitoneal injections of CNPS and paclitaxel were administered, respectively. At time points ranging from 10 min to 7 days, we measured the concentration of paclitaxel in blood, mesenteric lymph nodes and peritoneal lavage. The ratio of the area under the curve (AUC) in plasma of group A to that of group B was 0.6263. The ratio of AUC in lymph nodes of group A to group B was 0.7495 and that in peritoneal lavage was 1.25. The metabolic half-life of paclitaxel (t1/2) in plasma of group A was 1.607 times as long as that of group B. The t1/2 of paclitaxel in peritoneal lavage of group A was 0.879 as long as that of Group B. The t1/2 of paclitaxel in lymph nodes of group A was 1.097 as long as that of Group B. Intraperitoneal chemotherapy by CNPS was characterized by low drug concentration in blood, high drug concentration in peritoneal and high security, but lack of significant lymph targeting and lymphatic retention effect.